UK approved fewer new drugs than EU and US in year after Brexit transition
Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers The UK approved fewer new medicines than the EU and […]
Fears extra expense and paperwork caused by Brexit will make Britain unattractive to global drugmakers The UK approved fewer new medicines than the EU and […]
UK scientists are being denied from joining the €95 billion Horizon research funding programme as a dispute over the trade border in Northern Ireland gets […]
The MHRA has kicked off an eight-week consultation on proposals for changes to laws governing the conduct of clinical trials following the UK’s departure from […]
Post-pandemic, post-Brexit Britain must create a regulatory framework that both defines and aligns with international standards, or risk being left behind. If the UK creates […]
A 20% to 25% reduction in staffing at the UK Medicines and Healthcare products Regulatory Agency (MHRA) risks undermining the ability of the authority to […]
It’s fair to say this is the most interesting time ever for market access. Not only has COVID forced companies, governments and healthcare systems to […]
The UK Government and EU Commission trumpeted their Brexit trade deal, struck at the end of December, as ‘comprehensive’, the ‘biggest yet’. But a closer […]
UK chancellor Rishi Sunak has been urged to recognise the leading role that pharma companies are playing in the economy in this week’s budget. Sunak […]
UK assembly line at standstill as pharmaceutical company sets up in Amsterdam and plans EU expansion A Sussex pharmaceutical company has told how it had […]
Head of Welsh CBI tells committee pharmaceutical firm has had to move production to Dublin A Welsh pharmaceutical company has been forced to throw out […]
Moderna jab won’t be available in Britain until April but fourth vaccine may soon come online Coronavirus – latest updates See all our coronavirus coverage […]
The post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some degree of stability – but also plenty […]
Analysis: From retail to aviation to pharmaceuticals, we look at what will change from 1 January After months of tortuous negotiations between the UK and […]
NHS leaders have written to the UK prime minister urging him to extend the Brexit transition period by a month to avoid plunging the healthcare […]
Companies are praying a trade agreement can be struck, but must prepare for talks to fail. Which will be most affected? The scene is set […]
The UK and EU have reached an agreement on border checks for Northern Ireland that should guarantee that trade in medicines and food continues without […]
The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other […]
EMA executive director Guido Rasi has ended his second term at the helm of the EU medicines regulator, with Emer Cooke taking the wheel and […]
Businesses already struggling with the fallout from Covid-19 will be forced to deal with a mountain of new bureaucracy in the middle of a deep […]
The UK government has asked pharma companies to build a six-week stockpile of drugs and find alternative shipping routes to the congested Dover-Calais crossing as […]
Companies should ensure six weeks’ worth of drugs for end of transition period, DHSC says Pharmaceutical companies should stockpile six weeks’ worth of drugs to […]
Copyright © 2024 | WordPress Theme by MH Themes